Hostname: page-component-745bb68f8f-hvd4g Total loading time: 0 Render date: 2025-02-06T07:41:19.531Z Has data issue: false hasContentIssue false

Human herpesvirus 6

Published online by Cambridge University Press:  11 February 2004

Stephen Dewhurst
Affiliation:
Department of Microbiology and Immunology, and Cancer Center, University of Rochester Medical Center, 575 Elmwood Avenue, Box 672, Rochester NY 14642 USA.
David Skrincosky
Affiliation:
Department of Microbiology and Immunology, University of Rochester Medical Center, 575 Elmwood Avenue, Box 672, Rochester NY 14642 USA.
Nanette van Loon
Affiliation:
Department of Microbiology and Immunology, University of Rochester Medical Center, 575 Elmwood Avenue, Box 672, Rochester NY 14642 USA.
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Human herpesvirus 6 (HHV-6) is a T-lymphotropic herpesvirus, which infects almost all children by the age of two years and persists lifelong. Two distinct variants of HHV-6, HHV-6A and HHV-6B, have been described, and the latter has been shown to be a common cause of acute febrile illnesses in young children, including exanthem subitum (roseola). HHV-6 has also been associated with a number of neurological disorders, including encephalitis and seizures, and the virus has been postulated to play a role in acquired immunodeficiency syndrome (AIDS), multiple sclerosis (MS) and chronic fatigue immunodeficiency syndrome (CFIDS). This review provides a critical summary of research conducted on HHV-6.

Type
Review Article
Copyright
© Cambridge University Press 1997